[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Tao Liu\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":124},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,38,65,94],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":27,"lastUpdatePostDateStruct":28,"startDateStruct":31,"completionDateStruct":33,"leadSponsor":35,"locationsCount":4},"100628911","a-proof-of-concept-study-of-ultrasound-stimulation-of-the-neck-to-enhance-anti-shock-efficacy-100628911",false,"NCT07467798","A Proof-of-concept Study of Ultrasound Stimulation of the Neck to Enhance Anti-shock Efficacy","Inclusion Criteria:\n\n* Patients with shock who are ≥18 years of age and have a systolic blood pressure (SBP) between 60 mmHg and 90 mmHg;\n* Patients with arterial blood pressure monitoring or peripheral arterial pressure monitoring with intervals of single-digit minutes;\n* Patients with mild to moderate shock with a shock index (SI) of 1 ≤ SI ≤ 2;\n* Patients with complete medical records.\n\nExclusion Criteria:\n\n* Patients with unstable condition and estimated survival time \\\u003C24 hours;\n* Patients requiring emergency surgery to achieve control of their condition;\n* Perioperative patients requiring surgery due to conditions other than hypotension;\n* Pregnant or lactating patients;\n* Patients with neck wounds and\u002For carotid artery plaques who are unsuitable for ultrasound stimulation of the left carotid sinus;\n* Patients deemed unsuitable for inclusion by the investigator.","ALL","18 Years",{"count":18,"type":19},30,"ESTIMATED","INTERVENTIONAL",[22],"NA","The objective of this clinical study is to evaluate the initial efficacy and safety of LIPUS as an adjunct to standard therapy in patients with shock. The investigators will invite patients to participate in a proof-of-concept study investigating the efficacy of neck ultrasound stimulation to enhance anti-shock treatment, involving brief exposure to low-intensity pulsed ultrasound. This study examines whether LIPUS can enhance blood pressure in patients with shock, improve the efficacy of antihypotensive treatment, and reduce the dosage and duration of vasoactive drugs during active pharmacological therapy. By applying LIPUS as an adjunct to conventional treatment in clinical cases of shock, we aim to determine the clinical value of LIPUS and establish a theoretical foundation for developing innovative new therapies for shock.",[25],"Shock","NOT_YET_RECRUITING","2026-04-17",{"date":29,"type":30},"2026-04-22","ACTUAL",{"date":32,"type":19},"2026-05",{"date":34,"type":19},"2027-11",{"name":36,"class":37},"Tao Liu","OTHER",{"id":39,"slug":40,"hasResults":11,"nctId":41,"briefTitle":42,"officialTitle":42,"acronym":43,"eligibilityCriteria":44,"healthyVolunteers":45,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":46,"targetDuration":4,"studyType":20,"phases":47,"briefSummary":48,"conditions":49,"keywords":51,"overallStatus":55,"whyStopped":4,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":63,"locationsCount":64},"100599454","effects-of-non-invasive-superficial-craniocervical-lymphatic-drainage-nscld-on-memory-and-cognitive-function-in-adults-with-sleep-deprivation-a-proof-of-concept-study-100599454","NCT07084701","Effects of Non-Invasive Superficial Craniocervical Lymphatic Drainage (NSCLD) on Memory and Cognitive Function in Adults With Sleep Deprivation: A Proof-of-Concept Study","NSCLD","Inclusion Criteria:\n\n* College student ≥18 years, all of whom have passed a standardized entrance examination;\n* No failed exams during the course of study;\n* Sleep deprivation;\n* In good health, with no mental or psychological disorders;\n* No recent use of medications that may affect memory and cognition;\n* Voluntary participation and able to undergo cognitive function and memory testing;\n* Informed consent provided\n\nExclusion Criteria:\n\n* Pregnant or breastfeeding women.\n* Presence of acute or chronic medical conditions (e.g., severe hypertension, diabetes, cardiovascular disease) that could confound the results.\n* History of craniocervical trauma or surgery.\n* Current use of sedative or anxiolytic medications that could influence sleep or cognitive function.\n* Participants who are unable to follow the procedures or complete the assessments",true,{"count":18,"type":19},[22],"This Effects of Non-Invasive Superficial Craniocervical Lymphatic Drainage (NSCLD) on Memory and Cognitive Function in Adults with Sleep deprivation: A Proof-of-Concept Study aims to investigate the effects of Non-Invasive Superficial Craniocervical Lymphatic Drainage (NSCLD) on memory and cognitive function in adults experiencing sleep deprivation(SD). Given the known impact of SD on cognitive performance, this study seeks to explore whether NSCLD, as a non-invasive intervention, can mitigate the cognitive impairments associated with SD.",[50],"Sleep Deprivation",[50,52,53,54,43],"Non-Invasive Superficial Craniocervical Lymphatic Drainage","Memory","Cognitive Function","RECRUITING","2026-01-11",{"date":58,"type":30},"2026-01-13",{"date":60,"type":30},"2025-09-15",{"date":62,"type":19},"2026-12",{"name":36,"class":37},1,{"id":66,"slug":67,"hasResults":11,"nctId":68,"briefTitle":69,"officialTitle":70,"acronym":4,"eligibilityCriteria":71,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":72,"targetDuration":4,"studyType":20,"phases":74,"briefSummary":75,"conditions":76,"keywords":78,"overallStatus":55,"whyStopped":4,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":93},"100611428","aspirin-continuation-or-discontinuation-in-conservative-treatment-for-chronic-subdural-hematoma-100611428","NCT07240454","Aspirin Continuation or Discontinuation in Conservative Treatment for Chronic Subdural Hematoma","Safety and Efficacy of Aspirin Continuation or Discontinuation in Conservative Treatment for Chronic Subdural Hematoma: A Randomized Clinical Trial","Inclusion Criteria:\n\n* Age ≥18 years, male or female;\n* Confirmed diagnosis of chronic subdural hematoma (cSDH) by cranial CT and\u002For MRI;\n* Intended for conservative management (i.e., no surgical evacuation indication at enrollment);\n* Regular aspirin use at enrollment;\n* Informed consent signed by the patient or legal representative.\n\nExclusion Criteria:\n\n* Patients requiring emergency surgery to remove hematoma at enrollment;\n* Concurrent use of other anticoagulants or antiplatelet agents that cannot be discontinued according to the study protocol;\n* cSDH secondary to other diseases or conditions (e.g., excessive drainage from ventriculoperitoneal shunts, intracranial tumors);\n* Active bleeding events or major cardiac events (e.g., acute myocardial infarction, unstable angina, or revascularization surgery) within 30 days prior to enrollment;\n* Known bleeding disorders (e.g., hemophilia, severe thrombocytopenia);\n* Individuals unable to provide informed consent or for whom completion of follow-up is anticipated to be difficult.",{"count":73,"type":19},143,[22],"This clinical study aims to learn about the efficacy and safety of aspirin continuation or discontinuation in conservative treatment for chronic subdural hematoma. All participants received standard conservative treatment for chronic subdural hematoma, with a randomized intervention to either continue or discontinue aspirin administration. By participating in this study, participants can receive additional scientific guidance on aspirin medication management beyond routine conservative treatment, thereby optimizing individualized therapy.",[77],"Chronic Subdural Hematoma",[77,79,80,81,82,83,84],"Aspirin","Conservative Treatment","Randomized Clinical Trial","Safety","Efficacy","cSDH","2025-11-16",{"date":87,"type":30},"2025-11-21",{"date":89,"type":30},"2025-10-15",{"date":91,"type":19},"2028-12",{"name":36,"class":37},2,{"id":95,"slug":96,"hasResults":11,"nctId":97,"briefTitle":98,"officialTitle":98,"acronym":99,"eligibilityCriteria":100,"healthyVolunteers":11,"sex":15,"minAge":4,"maxAge":4,"enrollmentInfo":101,"targetDuration":103,"studyType":104,"phases":4,"briefSummary":105,"conditions":106,"keywords":108,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":116,"lastUpdatePostDateStruct":117,"startDateStruct":119,"completionDateStruct":121,"leadSponsor":123,"locationsCount":4},"100564465","the-registry-study-on-multimodality-treatment-for-cerebral-hemorrhage-100564465","NCT06629532","The REgistry Study on Multimodality trEAtment foR Cerebral Hemorrhage","RESEARCH","Inclusion Criteria:\n\n* Cerebral hemorrhage\n\nExclusion Criteria:\n\n\\-",{"count":102,"type":19},100000,"6 Months","OBSERVATIONAL","The REgistry Study on multimodality trEAtment foR Cerebral Hemorrhage (RESEARCH) aims to address these challenges by establishing a comprehensive national registry. This initiative will collect detailed, longitudinal data on the clinical characteristics, treatment modalities, and outcomes of patients with ICH across various regions. By leveraging a wide array of treatment data - including medical management, surgical interventions, and rehabilitative strategies - the RESEARCH registry intends to provide a granular view of current treatment landscapes and their direct impact on patient recovery and quality of life.",[107],"Intracerebral Hemorrhage",[109,110,111,112,113,114,115],"intracerebral hemorrhage","Outcome","Management","Surgical interventions","Real-world","Disparities","Multicentric data","2024-10-03",{"date":118,"type":30},"2024-10-08",{"date":120,"type":19},"2024-10-15",{"date":122,"type":19},"2049-10-15",{"name":36,"class":37},""]